Sick sinus syndrome medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 17: Line 17:
**Oral vagolytic agents such as glycopyrrolate or atropine
**Oral vagolytic agents such as glycopyrrolate or atropine
*Asymptomatic patients are usually monitored without therapy.
*Asymptomatic patients are usually monitored without therapy.
== 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay <ref name="KusumotoSchoenfeld2019">{{cite journal|last1=Kusumoto|first1=Fred M.|last2=Schoenfeld|first2=Mark H.|last3=Barrett|first3=Coletta|last4=Edgerton|first4=James R.|last5=Ellenbogen|first5=Kenneth A.|last6=Gold|first6=Michael R.|last7=Goldschlager|first7=Nora F.|last8=Hamilton|first8=Robert M.|last9=Joglar|first9=José A.|last10=Kim|first10=Robert J.|last11=Lee|first11=Richard|last12=Marine|first12=Joseph E.|last13=McLeod|first13=Christopher J.|last14=Oken|first14=Keith R.|last15=Patton|first15=Kristen K.|last16=Pellegrini|first16=Cara N.|last17=Selzman|first17=Kimberly A.|last18=Thompson|first18=Annemarie|last19=Varosy|first19=Paul D.|title=2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society|journal=Circulation|volume=140|issue=8|year=2019|issn=0009-7322|doi=10.1161/CIR.0000000000000627}}</ref> ==
=== Acute Medical Therapy for Bradycardia===
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]]
|-
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>In patients with SND associated with symptoms or hemodynamic compromise, atropine is reasonable to increase sinus rate ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki>
|}
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 22:14, 8 April 2020

Sick sinus syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sick sinus syndrome from other Diseases

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples

Echocardiography

X-ray

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Guidelines

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sick sinus syndrome medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sick sinus syndrome medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sick sinus syndrome medical therapy

CDC on Sick sinus syndrome medical therapy

Sick sinus syndrome medical therapy in the news

Blogs on Sick sinus syndrome medical therapy

Directions to Hospitals Treating Sick sinus syndrome

Risk calculators and risk factors for Sick sinus syndrome medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The management of sick sinus syndrome depends on the underlying cause and the presenting symptoms. After correcting the reversible causes of sick sinus syndrome, it can be managed by placing an implantable pacemaker. Asymptomatic patients are usually monitored without therapy.

Medical Therapy

The management of sick sinus syndrome depends on the underlying cause and the presenting symptoms. After correcting the reversible causes of sick sinus syndrome, it can be managed by placing an implantable pacemaker.[1]

  • Clinical indications of the implantable pacemaker include:
    • Patients with documented bradycardia and are symptomatic
    • Patients with chronotropic incompetence
    • Sinus node dysfunction secondary to medications necessitated by another medical condition
    • Patients with heart rate < 40 per minute
  • Asymptomatic patients are followed without any treatment.
  • Pharmacologic agents for the treatment of sick siuns syndrome include:
    • Caffeine
    • β-sympathomimetics (e.g., theophylline)
    • Oral vagolytic agents such as glycopyrrolate or atropine
  • Asymptomatic patients are usually monitored without therapy.

References

  1. Dakkak W, Doukky R. PMID 29261930. Missing or empty |title= (help)

Template:WH Template:WS